Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2002
06/27/2002WO2002030879A3 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
06/27/2002WO2002024613A3 Resorcinol derivatives
06/27/2002WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists
06/27/2002WO2002020501A3 Polyarylcarboxamides useful as lipid lowering agents
06/27/2002WO2002009648A3 Antimicrobial biaryl compounds
06/27/2002WO2001096298A3 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002WO2001018171A3 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
06/27/2002US20020082422 For use in dye sensitizing type solar battery
06/27/2002US20020082283 Increasing the function of the N-methylaspartic acid (NMDA) receptor without the inherent side-effects associated with modulation of the glutamate binding site
06/27/2002US20020082278 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases
06/27/2002US20020082266 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
06/27/2002US20020082262 Regulate the cellular transport proteins P- glycoprotein and MRP1 , which are the proteins believed to be responsible for multidrug resistance in cancer patients
06/27/2002US20020082260 Isoindolin-1-one-substituted propionamide glucokinase activators which increase insulin secretion in the treatment of type II diabetes
06/27/2002US20020082256 Compounds useful as anti-inflammatory agents
06/27/2002US20020082218 Certain thiol inhibitors of endothelin-converting enzyme
06/27/2002CA2432908A1 Diamines as modulators of chemokine receptor activity
06/27/2002CA2432640A1 Substituted stilbenes, their reactions and anticancer activity
06/26/2002EP1217000A1 Inhibitors of factor Xa and factor VIIa
06/26/2002EP1216988A1 Thioalkylamine derivatives and process for the preparation thereof
06/26/2002EP1216980A1 Carboxylic acid derivatives and drugs containing the same
06/26/2002EP1216245A1 Pharmaceutically active sulfonyl hydrazide derivatives
06/26/2002EP1216240A1 Amide compounds
06/26/2002EP1216231A2 INHIBITORS OF FACTOR Xa
06/26/2002EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
06/26/2002EP1216228A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
06/26/2002EP1216225A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
06/26/2002EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
06/26/2002EP1216221A2 Rxr modulators with improved pharmacologic profile
06/26/2002EP1007011A4 Lock and key micelles
06/26/2002EP0931067B1 D4 receptor selectivity piperazine derivatives
06/26/2002EP0909270B1 Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine
06/26/2002CN1355811A Integrain receptor antagaonists
06/26/2002CN1355791A Process for production of 2-pyridylpyridine derivatives
06/26/2002CN1355786A Substituted arylmalonic acid dinitriles as intermediates for preparation of herbicides
06/26/2002CN1086700C Benzothiophene compounds, intermediates, composition, and methods
06/26/2002CN1086578C Sulfonamides and their use
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410783 Salt formation with dicamba; dehydration
06/25/2002US6410781 α-aminoacetic acid derivatives-α4β7 receptor antagonists
06/25/2002US6410737 Hydrogenolysis of the corresponding hydrazine compound
06/25/2002US6410736 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/25/2002US6410600 Azine used as fungicides
06/25/2002US6410586 Modulators of protein tyrosine phosphatases (PTPases)
06/25/2002US6410585 Therapy for non-insulin depend diabetes
06/25/2002US6410573 Cardiovascular diseases; potassium channel modulator
06/25/2002US6410571 Viricides
06/25/2002US6410566 Cyclic amine derivatives and their use as drugs
06/25/2002US6410547 Phenylpyridine derivatives useful as phosphodiesterase inhibitors
06/25/2002US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents
06/25/2002US6410483 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
06/25/2002CA2203878C Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
06/20/2002WO2002048137A2 Substituted heterocyclic phthalic acid diamide arthropodicides
06/20/2002WO2002048124A2 Piperazine derivatives
06/20/2002WO2002048111A2 Method for producing 4-haloalkyl nicotine nitriles
06/20/2002WO2002048110A2 Composition for regulating animal growth, method of manufacture and use thereof
06/20/2002WO2002048106A2 Isoindolin-1-one glucokinase activators
06/20/2002WO2002048100A2 Thiosulphonic s-esters as material protective agent
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002047762A1 Serine protease inhibitors
06/20/2002WO2002030894A3 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002US20020077486 Platelet ADP receptor inhibitors
06/20/2002US20020077478 Reacting 2,5-disubstituted pyridine with silalating agent
06/20/2002US20020077475 Reacting 5-halo-2-substituted pyridines and pyrimidines magnesium to form Grignard compound which is reacted withN,N-dialkylformamide to form an aldehyde, reacting under acidic condition to form heteroarylamine compound
06/20/2002US20020077455 Protease inhibitors
06/20/2002US20020077341 C10 carbamoyloxy substituted taxanes
06/20/2002US20020077340 Pyridone inhibitors of fatty acid binding protein and method
06/20/2002US20020077338 HIV protease inhibitors
06/20/2002US20020077321 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
06/20/2002US20020076457 Extracts of plants of genus Euphorbia, in particular sap of Euphorbia peplus, Euphorbia hirta and/or Euphorbia drummondii; selective cytotoxicity against malignant melanomas and squamous cell carcinomas
06/20/2002DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane
06/20/2002DE10063114A1 Dichlorpyridylmethylcyanamidine Dichlorpyridylmethylcyanamidine
06/20/2002DE10063109A1 Dichlorpyridymethylimine Dichlorpyridymethylimine
06/20/2002DE10063008A1 Carbonsäureamidderivate Carboxamide
06/20/2002DE10061967A1 Preparation of 4-haloalkyl-nicotinonitrile, useful as a pesticide intermediate, comprises reacting 3-amino-1-haloalkyl-2-propenone with nitrile and cyclizing the novel 3-oxo-haloalkenylamino-substituted nitrile intermediate
06/20/2002DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers
06/20/2002DE10060807A1 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, ortho-substituted nitrogen-containing Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them
06/20/2002DE10059418A1 Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Ortho, meta-substituted Bisarylverbindungen, processes for their preparation, their use as a medicine as well as pharmaceutical compositions containing them
06/20/2002CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002CA2431250A1 Composition for regulating animal growth, method of manufacture and use thereof
06/19/2002EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
06/19/2002EP1215200A1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
06/19/2002EP1214322A2 Amino-triazolopyridine derivatives
06/19/2002EP1214316A1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
06/19/2002EP1214303A1 Heterocyclic compounds and methods of use thereof
06/19/2002EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
06/19/2002EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives
06/19/2002EP1214292A1 Tyrosine derivatives
06/19/2002EP1214062A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
06/19/2002EP0885233B1 Terpyridine-platinum(ii) complexes
06/19/2002CN1354169A Ammoxidation reaction in reaction zone
06/19/2002CN1086311C Oxidative ammonolysis of alkylpyridines
06/19/2002CN1086291C Primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
06/18/2002US6407249 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
06/18/2002US6407248 α-unsaturated amines, their production and use
06/18/2002US6407246 Reverse transcriptase inhibitors to treat hiv
06/18/2002US6407245 Herbicides